Picture of Englewood Lab logo

950140 Englewood Lab Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Englewood Lab, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsARSARSAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2.6113.15.6215.914.4
Depreciation
Amortisation
Non-Cash Items4.38-0.813.337.813.77
Unusual Items
Other Non-Cash Items
Changes in Working Capital-4.36-21.7-4.84-11.1-12.2
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities6.71-5.797.54169.47
Capital Expenditures-3.66-2.09-3.33-2.02-3.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items8.50.2320.039-3.99-2.03
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities4.84-1.86-3.3-6.01-5.74
Financing Cash Flow Items-0.790
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-6.855.8-2.9-9.827.56
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4.74-1.951.270.0910.3